These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8629666)

  • 21. [Role of ultrasensitive detection of TSH and free thyroxine in the surveillance of primary treated hypothyroidism (79 cases)].
    Sfar MH; Tabka Z; Chaieb L; Zebidi A
    Tunis Med; 1991 May; 69(5):353-6. PubMed ID: 1750146
    [No Abstract]   [Full Text] [Related]  

  • 22. Two cases of therapeutic failure associated with levothyroxine brand interchange.
    Copeland PM
    Ann Pharmacother; 1995 May; 29(5):482-5. PubMed ID: 7655130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of a physiologic replacement dose of levothyroxine in elderly patients with hypothyroidism.
    Davis FB; LaMantia RS; Spaulding SW; Wehmann RE; Davis PJ
    Arch Intern Med; 1984 Sep; 144(9):1752-4. PubMed ID: 6433829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levothyroxine in subclinical hypothyroidism: a lifelong therapy?
    Rosario PW
    Clin Endocrinol (Oxf); 2010 May; 72(5):718-20. PubMed ID: 19769619
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of refractory and severe hypothyroidism with sublingual levothyroxine in liquid formulation.
    Peirce C; Ippolito S; Lanas A; Pesce M; Pontieri G; Arpaia D; Sarnelli G; Biondi B
    Endocrine; 2018 Apr; 60(1):193-196. PubMed ID: 28702889
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of interchangeability of two brands of levothyroxine preparations with a third-generation TSH assay.
    Escalante DA; Arem N; Arem R
    Am J Med; 1995 Apr; 98(4):374-8. PubMed ID: 7709950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles.
    Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F
    Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative bioequivalence study of a new levothyroxine solution versus a reference L-thyroxine solution in normal healthy volunteers.
    Chassard D; Kerihuel JC; Caplain H; Tran Quang N; Thebault JJ
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():324-6. PubMed ID: 1820903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raloxifene causing malabsorption of levothyroxine.
    Siraj ES; Gupta MK; Reddy SS
    Arch Intern Med; 2003 Jun; 163(11):1367-70. PubMed ID: 12796075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current methodology to assess bioequivalence of levothyroxine sodium products is inadequate.
    Blakesley VA
    AAPS J; 2005 Mar; 7(1):E42-6. PubMed ID: 16146348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tablet formulation of levothyroxine is absorbed less well than powdered levothyroxine.
    Yamamoto T
    Thyroid; 2003 Dec; 13(12):1177-81. PubMed ID: 14751040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to use the new sensitive thyrotropin assays.
    Fatourechi V
    Postgrad Med; 2000 Dec; 108(7):25-6. PubMed ID: 11126140
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo comparison of levothyroxine preparations.
    Ramos-Gabatin A; Jacobson JM; Young RL
    JAMA; 1982 Jan; 247(2):203-5. PubMed ID: 7053460
    [No Abstract]   [Full Text] [Related]  

  • 34. Bioequivalence studies for levothyroxine.
    Bolton S
    AAPS J; 2005 Mar; 7(1):E47-53. PubMed ID: 16146349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients.
    Ain KB; Pucino F; Shiver TM; Banks SM
    Thyroid; 1993; 3(2):81-5. PubMed ID: 8369656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Levothyroxine and generics: current reflections].
    Orgiazzi J; Wémeau JL
    Rev Prat; 2014 Mar; 64(3):304-6. PubMed ID: 24851355
    [No Abstract]   [Full Text] [Related]  

  • 37. Levothyroxine sodium tablets: chemical equivalence and bioequivalence.
    Curry SH; Gums JG; Williams LL; Curry RW; Wolfson BB
    Drug Intell Clin Pharm; 1988; 22(7-8):589-91. PubMed ID: 3046889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothyroidism resulting from generic levothyroxine failure.
    Dong BJ; Brown CH
    J Am Board Fam Pract; 1991; 4(3):167-70. PubMed ID: 2053456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologic blood markers reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism.
    Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B
    Acta Med Hung; 1991; 48(1-2):33-43. PubMed ID: 1813856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of primary hypothyroidism in adult patients].
    Salmela P; Metso S; Moilanen L; Niskanen L; Nuutila P; Schalin-Jäntti C
    Duodecim; 2016; 132(1):33-42. PubMed ID: 27044179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.